{"name":"Pulmovant, Inc.","slug":"pulmovant-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Mosliciguat","genericName":"Mosliciguat","slug":"mosliciguat","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Mosliciguat","genericName":"Mosliciguat","slug":"mosliciguat","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5wJBVV95cUxNVGdkdnB5Ylk1NkNfZ1A4YUdmTDZXZjVyaGJGUldLSGdBZFNvQ0g2VnRNbmlQbjdWMExQTkJrU1ZEUjYtc0w3ZXdTMlBFMW95X1lBZGRDbVdKbFYxcy1fUDhlYUwzMTI2UC1oTjF3Zm9KNlRaTDJramVpOXNkS0hMT05FQ01sU284MklSYzh2UmRhaGQtSGthc3dnbUJJSW9WcGFIdVdlajg0UndMVW5zTTJtZG4xSVlTM1V1Ri1mRmh0ZGhfeUlvLXV2Q0dtZEZMSThFQWpOOFQ3R0lQTGlxLXF5RGFaaVdrelVlanAwS1lvMG52OGVxU2JHYV85MlFMQ0JSU0hMZ2dpNFU2dmEtNkJRd2xlMTE0R3N3ckw1LU45amMwZklSTnRGZExqSjl0RXBvckVaZGFtWXZtQjhoMkJiQk9Sd184ZlFwXzBCWUhnOGRaX29GYnIxb0pfNjhweTBWbFhrZw?oc=5","date":"2026-02-06","type":"trial","source":"GlobeNewswire","summary":"Pulmovant Announces Completion of Enrollment in the Phase 2 - GlobeNewswire","headline":"Pulmovant Announces Completion of Enrollment in the Phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOTl94NFo0V2ZDRFNuYzRqN3BUdThWLTJYajdtc3VzWTUycUJYYW1HaFpDYjhOMVRHeEtLUGJtV0pnd2xUMUdvTjdVTkJjQ1NfOUNta2hTWXNiNU1oNTZ0RmQyNVluc1Z0dFZIcEQwUldNS1Z0ZThmVlRjLU5JRWNYYkpuakh3dmJGbWdUWUk0MzcwQQ?oc=5","date":"2025-09-04","type":"pipeline","source":"Yahoo Finance","summary":"Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - Yahoo Finance","headline":"Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPTmd6Vm5xVV9INW93N3FBSmxUNy1JcTR5WFNOTFBpTEtpOXYxSFpvZmVJX29TV2RsVzFhdk5hUUVBRnY0WkM4alRielFOd2pyVGhTdnc3VW85UGNaclN6LUFxeVE3RHhyWFp0UDJDc1E4LXhSY2VDMFhfRThUeGFZeXZ2VExEZw?oc=5","date":"2024-09-11","type":"pipeline","source":"pharmaphorum","summary":"Roivant's new 'vant' emerges to advance Bayer lung drug - pharmaphorum","headline":"Roivant's new 'vant' emerges to advance Bayer lung drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNVHoydVlJbFJNdE1sNm1USWFCZnlqR0VMTGtrZGZiUkJFN1pSTDUyUWxJTVJyc3Q5Q2xwY1pNTVpuUS1udHl4QVlzeFZ6V3pWd3NlY2duejZwcmViVC1nSUdPX3ZDNEpSSWJ0cGhvYmVhOUIybUlscy1jb25VY3h2UjhKWEZoeW52bzRMOEpPS2Q1b3hiZjR3VGs5bFp4ZllQWlB1cTBjRE54R3MxdTQ0ODRn?oc=5","date":"2024-09-10","type":"deal","source":"BioCentury","summary":"Deals report: Roivant sets up Pulmovant to advance hypertension therapy - BioCentury","headline":"Deals report: Roivant sets up Pulmovant to advance hypertension therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNVHR0cEI5ZUdUT3pBNHY1YndqbFhjZUp2cWdVM2VtMGJYVjFPRGsyV0FmTkNWam42R2xsUmppRmd3N1dnYXgwVG9pUlJsVkNBVVRYT05FTHZGaFQ1cW0tajBSazY3QnNacHNpV09Tal95eHhubHVoRnp5bW1PYks5c3p1c2JEZ1V4ZTZZQ24tQVB1U0x1?oc=5","date":"2024-09-10","type":"deal","source":"statnews.com","summary":"Roivant acquires drug for pulmonary hypertension from Bayer | STAT - statnews.com","headline":"Roivant acquires drug for pulmonary hypertension from Bayer | STAT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQWmg5Xy1LdWNhS2NiU1VzTlNybHlPbEF3M2RrQlVBeEF3cUxuUVJsRndqSTlLcmxKczB3OHJPVTVNZXlvcUhCcEFHeUZoT3hGSEY2aGlKRDY1Nk0zSGZ4MktlMW04aEl0WnByUHVwLV9taWVhYkJVX2ZFUzZEY0dKUTEwUVBLRm5sVm9fLV96T25kbEZCS1B1RmlJUk1XQQ?oc=5","date":"2024-09-10","type":"pipeline","source":"Citeline News & Insights","summary":"Roivant’s Pulmovant Emerges After Stealth Development Plan - Citeline News & Insights","headline":"Roivant’s Pulmovant Emerges After Stealth Development Plan - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbnpMcjRqVVNDZDdtSHJoaThFejFyaU9nZUZ5dDRlTm9oSFNNU09YVEtpc3g2RFdPOXhuWE9vX1BuSG04Mld5Q0JzMFFaMExkYjlKZDJDcm1NN3BFSDJYaTBhdTdmaHAwWlFvRzhSeUc4UkxIS2pOZjlUSGhsakFLdDlabHVPTGdkZ09WT1ppOUtpeTdZRXh3emh5MmFvZ014azA3blNOUExqUQ?oc=5","date":"2024-09-10","type":"pipeline","source":"MedCity News","summary":"Bayer Asset Gives Roivant Sciences' New ‘Vant’ a Shot at Besting a United Therapeutics Lung Drug - MedCity News","headline":"Bayer Asset Gives Roivant Sciences' New ‘Vant’ a Shot at Besting a United Therapeutics Lung Drug","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}